Advancements in predicting outcomes in patients with glioma: a surgical perspective

References

• Shirahata M, Ono T, Stichel D, et al. Novel, improved grading system(s) for IDH-mutant astrocytic gliomas. Acta Neuropathol. 2018;136(1):153–166. Epub 2018/ 04/25. PubMed PMID: 29687258.
   PubMed Web of Science ®Google Scholar
• Brat DJ, Verhaak RG, Aldape KD, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 2015;372(26):2481–2498. Epub 2015/ 06/11. PubMed PMID: 26061751; PubMed Central PMCID: PMCPMC4530011.
   PubMed Web of Science ®Google Scholar
• Eckel-Passow JE, Lachance DH, Molinaro AM, et al. Glioma groups based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med. 2015. Epub 2015/06/11. PubMed PMID: 26061753. DOI:10.1056/NEJMoa1407279
   PubMed Web of Science ®Google Scholar
• Aibaidula A, Chan AK, Shi Z, et al. Adult IDH wild-type lower-grade gliomas should be further stratified. Neuro Oncol. 2017;19(10):1327–1337. Epub 2017/06/03. PubMed PMID: 28575485; PubMed Central PMCID: PMCPMC5596181.
   PubMed Web of Science ®Google Scholar
• Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. Epub 2016/05/10. PubMed PMID: 27157931.
   PubMed Web of Science ®Google Scholar
• Tannock IF, Hickman JA. Limits to personalized cancer medicine. N Engl J Med. 2016;375(13):1289–1294. Epub 2016/09/30. PubMed PMID: 27682039.
   PubMed Web of Science ®Google Scholar
• Wenger A, Ferreyra Vega S, Kling T, et al. Intra-tumor DNA methylation heterogeneity in glioblastoma; implications for DNA methylation-based classification. Neuro Oncol. 2019. Epub 2019/01/23. PubMed PMID: 30668814. DOI:10.1093/neuonc/noz011
   PubMedGoogle Scholar
• Sottoriva A, Spiteri I, Piccirillo SG, et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A. 2013;110(10):4009–4014. Epub 2013/ 02/16. PubMed PMID: 23412337; PubMed Central PMCID: PMC3593922.
   PubMed Web of Science ®Google Scholar
• Venteicher AS, Tirosh I, Hebert C, et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science. 2017;355(6332). Epub 2017/ 04/01. PubMed PMID: 28360267; PubMed Central PMCID: PMCPMC5519096. DOI:10.1126/science.aai8478
   PubMed Web of Science ®Google Scholar
• Patel AP, Tirosh I, Trombetta JJ, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344(6190):1396–1401. Epub 2014/ 06/14. PubMed PMID: 24925914; PubMed Central PMCID: PMC4123637
   PubMed Web of Science ®Google Scholar
• Klughammer J, Kiesel B, Roetzer T, et al. The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space. Nat Med. 2018. DOI:10.1038/s41591-018-0156-x
   PubMed Web of Science ®Google Scholar
• Johnson BE, Mazor T, Hong C, et al. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science. 2014;343(6167):189–193. Epub 2013/ 12/18. PubMed PMID: 24336570.
   PubMed Web of Science ®Google Scholar
• Stummer W, Pichlmeier U, Meinel T, et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7(5):392–401.
   PubMed Web of Science ®Google Scholar
• Jakola AS, Myrmel KS, Kloster R, et al. Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. Jama. 2012;308(18):1881–1888. Epub 2012/10/27. PubMed PMID: 23099483.
   PubMed Web of Science ®Google Scholar
• Katlic MR, Coleman J. Surgical intuition. Ann Surg. 2018;268(6):935–937. Epub 2018/04/27. PubMed PMID: 29697449.
   PubMed Web of Science ®Google Scholar
• Smits M, van den Bent MJ. Imaging correlates of adult glioma genotypes. Radiology. 2017;284(2):316–331. Epub 2017/07/21. PubMed PMID: 28723281.
   PubMed Web of Science ®Google Scholar
• Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563–577. Epub 2015/ 11/19. PubMed PMID: 26579733; PubMed Central PMCID: PMCPMC4734157.
   PubMed Web of Science ®Google Scholar
• Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006. Epub 2014/06/04. PubMed PMID: 24892406; PubMed Central PMCID: PMCPMC4059926.
   PubMed Web of Science ®Google Scholar
• Lasocki A, Tsui A, Tacey MA, et al. MRI grading versus histology: predicting survival of World Health Organization grade II-IV astrocytomas. AJNR Am J Neuroradiol. 2015;36(1):77–83. Epub 2014/ 08/12. PubMed PMID: 25104288.
   PubMed Web of Science ®Google Scholar
• Kunz M, Thon N, Eigenbrod S, et al. Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas. Neuro Oncol. 2011;13(3):307–316.
   PubMed Web of Science ®Google Scholar
• Suchorska B, Giese A, Biczok A, et al. Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma. Neuro Oncol. 2018;20(2):279–288. Epub 2017/ 10/11. PubMed PMID: 29016996; PubMed Central PMCID: PMCPMC5777500.
   PubMed Web of Science ®Google Scholar
• Kunz M, Albert NL, Unterrainer M, et al. Dynamic 18F-FET PET is a powerful imaging biomarker in gadolinium-negative gliomas. Neuro Oncol. 2019;21(2):274–284. Epub 2018/ 06/13. PubMed PMID: 29893965; PubMed Central PMCID: PMCPMC6374762.
   PubMed Web of Science ®Google Scholar
• Thon N, Kunz M, Lemke L, et al. Dynamic 18F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses. Int J Cancer. 2015;136(9):2132–2145.
   PubMed Web of Science ®Google Scholar
• Naslund O, Smits A, Forander P, et al. Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications. Acta Neurochir (Wien). 2018;160(7):1451–1460. Epub 2018/ 05/26. PubMed PMID: 29797098.
   PubMed Web of Science ®Google Scholar
• Widhalm G, Krssak M, Minchev G, et al. Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement. J Neurol Neurosurg Psychiatry. 2011;82(5):512–520. Epub 2010/10/26. PubMed PMID: 20971752.
   PubMed Web of Science ®Google Scholar
• Delgado AF, Fahlstrom M, Nilsson M, et al. Diffusion kurtosis imaging of gliomas grades II and III - a study of perilesional tumor infiltration, tumor grades and subtypes at clinical presentation. Radiol Oncol. 2017;51(2):121–129. Epub 2017/07/26. PubMed PMID: 28740446; PubMed Central PMCID: PMCPMC5514651.
   PubMed Web of Science ®Google Scholar
• Tietze A, Choi C, Mickey B, et al. Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting. J Neurosurg. 2017:1–8. Epub 2017/ 03/17. PubMed PMID: 28298040. DOI:10.3171/2016.10.jns161793
   Web of Science ®Google Scholar
• Choi C, Raisanen JM, Ganji SK, et al. Prospective longitudinal analysis of 2-hydroxyglutarate magnetic resonance spectroscopy identifies broad clinical utility for the management of patients with IDH-mutant glioma. J Clin Oncol. 2016;34(33):4030–4039. Epub 2017/ 03/02. PubMed PMID: 28248126.
   PubMed Web of Science ®Google Scholar
• Leather T, Jenkinson MD, Das K, et al. Magnetic resonance spectroscopy for detection of 2-hydroxyglutarate as a biomarker for IDH mutation in gliomas. Metabolites. 2017;7(2). Epub 2017/06/21. PubMed PMID: 28629182. DOI:10.3390/metabo7020029
   PubMed Web of Science ®Google Scholar
• Broen MPG, Smits M, Wijnenga MMJ, et al. The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study. Neuro Oncol. 2018;20(10):1393–1399. Epub 2018/03/29. PubMed PMID: 29590424; PubMed Central PMCID: PMCPMC6120363.
   PubMed Web of Science ®Google Scholar
• Johnson DR, Kaufmann TJ, Patel SH, et al. There is an exception to every rule-T2-FLAIR mismatch sign in gliomas. Neuroradiology. 2019;61(2):225–227. Epub 2018/ 12/20. PubMed PMID: 30565056.
   PubMed Web of Science ®Google Scholar
• Patel SH, Poisson LM, Brat DJ, et al. T2-FLAIR mismatch, an imaging biomarker for IDH and 1p/19q status in lower-grade gliomas: a TCGA/TCIA project. Clin Cancer Res. 2017;23(20):6078–6085. Epub 2017/ 07/29. PubMed PMID: 28751449.
   PubMed Web of Science ®Google Scholar
• Lee MK, Park JE, Jo Y, et al. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign. Eur Radiol. 2019. Epub 2019/ 08/26. PubMed PMID: 31446467. DOI:10.1007/s00330-019-06395-2
   Web of Science ®Google Scholar
• Jakola AS, Zhang YH, Skjulsvik AJ, et al. Quantitative texture analysis in the prediction of IDH status in low-grade gliomas. Clin Neurol Neurosurg. 2018;164:114–120. Epub 2017/ 12/09. PubMed PMID: 29220731.
   PubMed Web of Science ®Google Scholar
• Mazurowski MA, Clark K, Czarnek NM, et al. Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with the cancer genome atlas data. J Neurooncol. 2017. Epub 2017/ 05/05. PubMed PMID: 28470431. DOI:10.1007/s11060-017-2420-1
   Web of Science ®Google Scholar
• Shofty B, Artzi M, Ben Bashat D, et al. MRI radiomics analysis of molecular alterations in low-grade gliomas. Int J Comput Assist Radiol Surg. 2018;13(4):563–571. Epub 2017/ 12/23. PubMed PMID: 29270916.
   PubMed Web of Science ®Google Scholar
• Yu J, Shi Z, Lian Y, et al. Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma. Eur Radiol. 2017;27(8):3509–3522. Epub 2016/ 12/23. PubMed PMID: 28004160.
   PubMed Web of Science ®Google Scholar
• Park YW, Han K, Ahn SS, et al. Prediction of IDH1-mutation and 1p/19q-codeletion status using preoperative MR imaging phenotypes in lower grade gliomas. AJNR Am J Neuroradiol. 2018;39(1):37–42. Epub 2017/ 11/11. PubMed PMID: 29122763.
   PubMed Web of Science ®Google Scholar
• Han Y, Xie Z, Zang Y, et al. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas. J Neurooncol. 2018;140(2):297–306. Epub 2018/08/12. PubMed PMID: 30097822.
   PubMed Web of Science ®Google Scholar
• Tan Y, Zhang ST, Wei JW, et al. A radiomics nomogram may improve the prediction of IDH genotype for astrocytoma before surgery. Eur Radiol. 2019;29(7):3325–3337. Epub 2019/04/12. PubMed PMID: 30972543.
   PubMed Web of Science ®Google Scholar
• Skogen K, Schulz A, Dormagen JB, et al. Diagnostic performance of texture analysis on MRI in grading cerebral gliomas. Eur J Radiol. 2016;85(4):824–829. Epub 2016/03/15. PubMed PMID: 26971430.
   PubMed Web of Science ®Google Scholar
• LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521(7553):436–444. Epub 2015/ 05/29. PubMed PMID: 26017442.
   PubMed Web of Science ®Google Scholar
• Chang K, Bai HX, Zhou H, et al. Residual convolutional neural network for the determination of IDH Status in low- and high-grade gliomas from MR imaging. Clin Cancer Res. 2017. Epub 2017/11/24. PubMed PMID: 29167275. DOI:10.1158/1078-0432.ccr-17-2236
   Web of Science ®Google Scholar
• Akkus Z, Ali I, Sedlar J, et al. Predicting deletion of chromosomal arms 1p/19q in low-grade gliomas from MR images using machine intelligence. J Digit Imaging. 2017;30(4):469–476. Epub 2017/06/11. PubMed PMID: 28600641; PubMed Central PMCID: PMCPMC5537096.
   PubMed Web of Science ®Google Scholar
• Ge C, Gu IY, Jakola AS, et al. Deep learning and multi-sensor fusion for glioma classification using multistream 2D convolutional networks. Conf Proc IEEE Eng Med Biol Soc. 2018;2018:5894–5897. Epub 2018/11/18. PubMed PMID: 30441677.
   PubMedGoogle Scholar
• Liang S, Zhang R, Liang D, et al. Multimodal 3D DenseNet for IDH genotype prediction in gliomas. Genes (Basel). 2018;9(8). Epub 2018/ 08/01 PubMed PMID: 30061525; PubMed Central PMCID: PMCPMC6115744. DOI:10.3390/genes9080382
   Web of Science ®Google Scholar
• Li Z, Wang Y, Yu J, et al. Deep learning based radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma. Sci Rep. 2017;7(1):5467. Epub 2017/07/16. PubMed PMID: 28710497; PubMed Central PMCID: PMCPMC5511238.
   PubMedGoogle Scholar
• Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352(10):997–1003. Epub 2005/03/11. PubMed PMID: 15758010.
   PubMed Web of Science ®Google Scholar
• Kickingereder P, Neuberger U, Bonekamp D, et al. Radiomic subtyping improves disease stratification beyond key molecular, clinical and standard imaging characteristics in patients with glioblastoma. Neuro Oncol. 2017. Epub 2017/ 10/17. PubMed PMID: 29036412. DOI:10.1093/neuonc/nox188
   PubMed Web of Science ®Google Scholar
• Han Y, Lf Y, Wang XB, et al. Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis. BMC Cancer. 2018;18(1):215. Epub 2018/02/23. PubMed PMID: 29467012; PubMed Central PMCID: PMCPMC5822523.
   PubMed Web of Science ®Google Scholar
• Tixier F, Um H, Bermudez D, et al. Preoperative MRI-radiomics features improve prediction of survival in glioblastoma patients over MGMT methylation status alone. Oncotarget. 2019;10(6):660–672. Epub 2019/02/19. PubMed PMID: 30774763; PubMed Central PMCID: PMCPMC6363013.
   PubMedGoogle Scholar
• Drabycz S, Roldan G, de Robles P, et al. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging. Neuroimage. 2010;49(2):1398–1405. Epub 2009/10/03. PubMed PMID: 19796694.
   PubMed Web of Science ®Google Scholar
• Li ZC, Bai H, Sun Q, et al. Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: a multicentre study. Eur Radiol. 2018;28(9):3640–3650. Epub 2018/ 03/23. PubMed PMID: 29564594.
   PubMed Web of Science ®Google Scholar
• Miller AM, Shah RH, Pentsova EI, et al. Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid. Nature. 2019;565(7741):654–658. Epub 2019/01/25. PubMed PMID: 30675060; PubMed Central PMCID: PMCPMC6457907.
   PubMed Web of Science ®Google Scholar
• Best MG, Sol N, Zijl S, et al. Liquid biopsies in patients with diffuse glioma. Acta Neuropathol. 2015;129(6):849–865. Epub 2015/02/28. PubMed PMID: 25720744; PubMed Central PMCID: PMCPMC4436687.
   PubMed Web of Science ®Google Scholar
• Shaw EG, Berkey B, Coons SW, et al. Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. J Neurosurg. 2008;109(5):835–841.
   PubMed Web of Science ®Google Scholar
• Albert FK, Forsting M, Sartor K, et al. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery. 1994;34(1):45–61.
   PubMed Web of Science ®Google Scholar
• Senft C, Bink A, Franz K, et al. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol. 2011;12:997–1003. Epub 2011/ 08/27.
   PubMed Web of Science ®Google Scholar
• Lau D, Hervey-Jumper SL, Han SJ, et al. Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve. J Neurosurg. 2018;128(5):1410–1418. Epub 2017/ 07/22. Jns161811. PubMed PMID: 28731401.
   PubMed Web of Science ®Google Scholar
• Sezer S, van Amerongen MJ, Delye HHK, et al. Accuracy of the neurosurgeons estimation of extent of resection in glioblastoma. Acta Neurochir (Wien). 2019. Epub 2019/ 10/28. PubMed PMID: 31656985. DOI:10.1007/s00701-019-04089-8
   PubMed Web of Science ®Google Scholar
• Sonabend AM, Zacharia BE, Cloney MB, et al. Defining glioblastoma resectability through the wisdom of the crowd: a proof-of-principle study. Neurosurgery. 2017;80(4):590–601. Epub 2016/ 08/11. PubMed PMID: 27509070; PubMed Central PMCID: PMCPMC5888974.
   PubMed Web of Science ®Google Scholar
• Hendriks EJ, Idema S, Hervey-Jumper SL, et al. Preoperative resectability estimates of nonenhancing glioma by neurosurgeons and a resection probability map. Neurosurgery. 2018. Epub 2018/ 11/14. PubMed PMID: 30423155. DOI:10.1093/neuros/nyy487
   Web of Science ®Google Scholar
• De Witt Hamer PC, Hendriks EJ, Mandonnet E, et al. Resection probability maps for quality assessment of glioma surgery without brain location bias. PLoS ONE. 2013;8(9):e73353. Epub 2013/ 09/17. PubMed PMID: 24039922; PubMed Central PMCID: PMC3765204.
   PubMed Web of Science ®Google Scholar
• Ius T, Angelini E, Thiebaut de Schotten M, et al. Evidence for potentials and limitations of brain plasticity using an atlas of functional resectability of WHO grade II gliomas: towards a “minimal common brain”. Neuroimage. 2011;56(3):992–1000. Epub 2011/03/19. PubMed PMID: 21414413.
   PubMed Web of Science ®Google Scholar
• Muller DMJ, Robe P, Eijgelaar RS, et al. Comparing glioblastoma surgery decisions between teams using brain maps of tumor locations, biopsies, and resections. JCO Clin Cancer Inform. 2019;3:1–12. Epub 2019/01/24. PubMed PMID: 30673344.
   PubMed Web of Science ®Google Scholar
• De Witt Hamer PC, Ho VKY, Zwinderman AH, et al. Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch quality registry for neuro surgery. J Neurooncol. 2019;144(2):313–323. Epub 2019/06/27. PubMed PMID: 31236819; PubMed Central PMCID: PMCPMC6700042.
   PubMed Web of Science ®Google Scholar
• Costabile JD, Alaswad E, D’Souza S, et al. Current applications of diffusion tensor imaging and tractography in intracranial tumor resection. Front Oncol. 2019;9:426. Epub 2019/06/14. PubMed PMID: 31192130; PubMed Central PMCID: PMCPMC6549594.
   PubMed Web of Science ®Google Scholar
• Freyschlag CF, Kerschbaumer J, Pinggera D, et al. Preoperative prediction of language function by diffusion tensor imaging. Brain Inform. 2017;4(3):201–205. Epub 2017/05/06. PubMed PMID: 28474309; PubMed Central PMCID: PMCPMC5563300.
   PubMedGoogle Scholar
• Lam S, Lucente G, Schneider H, et al. TMS motor mapping in brain tumor patients: more robust maps with an increased resting motor threshold. Acta Neurochir (Wien). 2019;161(5):995–1002. Epub 2019/ 03/31. PubMed PMID: 30927156.
   PubMed Web of Science ®Google Scholar
• Raffa G, Scibilia A, Conti A, et al. The role of navigated transcranial magnetic stimulation for surgery of motor-eloquent brain tumors: a systematic review and meta-analysis. Clin Neurol Neurosurg. 2019;180:7–17. Epub 2019/ 03/15. PubMed PMID: 30870762.
   PubMed Web of Science ®Google Scholar
• Raffa G, Conti A, Scibilia A, et al. Functional reconstruction of motor and language pathways based on navigated transcranial magnetic stimulation and DTI fiber tracking for the preoperative planning of low grade glioma surgery: a new tool for preservation and restoration of eloquent networks. Acta Neurochir Suppl. 2017;124:251–261. Epub 2017/ 01/26. PubMed PMID: 28120081.
   PubMedGoogle Scholar
• Agarwal S, Hua J, Sair HI, et al. Repeatability of language fMRI lateralization and localization metrics in brain tumor patients. Hum Brain Mapp. 2018;39(12):4733–4742. Epub 2018/08/05. PubMed PMID: 30076768; PubMed Central PMCID: PMCPMC6218318.
   PubMed Web of Science ®Google Scholar
• Lehericy S, Cohen L, Bazin B, et al. Functional MR evaluation of temporal and frontal language dominance compared with the Wada test. Neurology. 2000;54(8):1625–1633. Epub 2000/04/13. PubMed PMID: 10762504.
   PubMed Web of Science ®Google Scholar
• Suarez RO, Whalen S, Nelson AP, et al. Threshold-independent functional MRI determination of language dominance: a validation study against clinical gold standards. Epilepsy Behav. 2009;16(2):288–297. Epub 2009/ 09/08. PubMed PMID: 19733509; PubMed Central PMCID: PMCPMC2758322.
   PubMed Web of Science ®Google Scholar
• Weng HH, Noll KR, Johnson JM, et al. Accuracy of presurgical functional MR imaging for language mapping of brain tumors: a systematic review and meta-analysis. Radiology. 2018;286(2):512–523. Epub 2017/ 10/06. PubMed PMID: 28980887.
   PubMed Web of Science ®Google Scholar
• Jakola AS, Unsgård G, Myrmel KS, et al. Low grade gliomas in eloquent locations – implications for surgical strategy, survival and long term quality of life. PLoS ONE. 2012;7(12):e51450.
   PubMed Web of Science ®Google Scholar
• Ferroli P, Broggi M, Schiavolin S, et al. Predicting functional impairment in brain tumor surgery: the big five and the milan complexity scale. Neurosurg Focus. 2015;39(6):E14. Epub 2015/ 12/02. PubMed PMID: 26621412.
   PubMed Web of Science ®Google Scholar
• Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. New York: Columbia University Press; 1949, p. 191–205.
   Google Scholar
• Chang EF, Smith JS, Chang SM, et al. Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg. 2008;109(5):817–824. PubMed PMID: 18976070.
   PubMed Web of Science ®Google Scholar
• Kreth F-W, Thon N, Simon M, et al. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy. Ann Oncol. 2013;24(12):3117–3123.
   PubMed Web of Science ®Google Scholar
• Capelle L, Fontaine D, Mandonnet E, et al. Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases. J Neurosurg. 2013:1–12. PubMed PMID: 23495881. DOI:10.3171/2013.1.JNS121
   Web of Science ®Google Scholar
• Gulati S, Jakola AS, Nerland US, et al. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma. World Neurosurg. 2011;76(6):572–579. Epub 2012/ 01/19. PubMed PMID: 22251506.
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Mukherjee DM, Chaichana KL, et al. Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery. 2009;65(3):463–470.
   PubMed Web of Science ®Google Scholar
• Rahman M, Abbatematteo J, De Leo EK, et al. The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma. J Neurosurg. 2017;127(1):123–131. Epub 2016/ 10/01. PubMed PMID: 27689459.
   PubMed Web of Science ®Google Scholar
• Sagberg LM, Drewes C, Jakola AS, et al. Accuracy of operating neurosurgeons’ prediction of functional levels after intracranial tumor surgery. J Neurosurg. 2016:1–8. Epub 2016/ 06/18. PubMed PMID: 27315026. DOI:10.3171/2016.3.jns152927
   Web of Science ®Google Scholar
• Brennum J, Maier CM, Almdal K, et al. Primo non nocere or maximum survival in grade 2 gliomas? A medical ethical question. Acta Neurochir (Wien). 2014. Epub 2014/ 12/21. PubMed PMID: 25526721. DOI:10.1007/s00701-014-2304-5
   PubMed Web of Science ®Google Scholar
• Godolphin W. The role of risk communication in shared decision making. BMJ. 2003;327(7417):692–693. Epub 2003/ 09/27. PubMed PMID: 14512449; PubMed Central PMCID: PMC200791.
   PubMed Web of Science ®Google Scholar
• Barry MJ, Edgman-Levitan S. Shared decision making — the pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780–781. PubMed PMID: 22375967.
   PubMed Web of Science ®Google Scholar
• De Witt Hamer PC, Gil Robles S, Zwinderman AH, et al. Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. J Clin Oncol. 2012;30:2559–2565. Epub 2012/ 04/25. PubMed PMID: 22529254.
   PubMed Web of Science ®Google Scholar
• Antonsson M, Jakola A, Longoni F, et al. Post-surgical effects on language in patients with presumed low-grade glioma. Acta Neurol Scand. 2017. Epub 2017/ 12/22. PubMed PMID: 29265169. DOI:10.1111/ane.12887
   PubMed Web of Science ®Google Scholar
• Seidel K, Beck J, Stieglitz L, et al. The warning-sign hierarchy between quantitative subcortical motor mapping and continuous motor evoked potential monitoring during resection of supratentorial brain tumors. J Neurosurg. 2013;118(2):287–296. Epub 2012/ 12/04. PubMed PMID: 23198802.
   PubMed Web of Science ®Google Scholar
• Sagberg LM, Solheim O, Jakola AS. Quality of survival the 1st year with glioblastoma: a longitudinal study of patient-reported quality of life. J Neurosurg. 2015:1–9. Epub 2015/ 10/03. PubMed PMID: 26430849. DOI:10.3171/2015.4.jns15194
   Web of Science ®Google Scholar
• Carstam L, Smits A, Milos P, et al. Neurosurgical patterns of care for diffuse low-grade gliomas in Sweden between 2005 and 2015. Neuro-Oncol Pract. 2019;6(2):124–133. Epub 2019/04/06. PubMed PMID: 30949360; PubMed Central PMCID: PMCPMC6440530.
   PubMed Web of Science ®Google Scholar
• Ibañez FAL, Hem S, Ajler P, et al. A new classification of complications in neurosurgery. World Neurosurg. 2011; 75 (5–6): 709–715.
   PubMed Web of Science ®Google Scholar
• Rosenlund L, Degsell E, Jakola AS. Moving from clinician-defined to patient-reported outcome measures for survivors of high-grade glioma. Patient Relat Outcome Meas. 2019;10:267.
   PubMed Web of Science ®Google Scholar
• Drewes C, Sagberg LM, Jakola AS, et al. Perioperative and postoperative quality of life in glioma patients - A longitudinal cohort study. World Neurosurg. 2018. Epub 2018/06/20. PubMed PMID: 29920391. DOI:10.1016/j.wneu.2018.06.052
   PubMed Web of Science ®Google Scholar
• Bo HK, Solheim O, Kvistad KA, et al. Intraoperative 3D ultrasound-guided resection of diffuse low-grade gliomas: radiological and clinical results. J Neurosurg. 2019:1–12. Epub 2019/ 02/06. PubMed PMID: 30717057. DOI:10.3171/2018.10.Jns181290
   PubMed Web of Science ®Google Scholar
• Salo J, Niemela A, Joukamaa M, et al. Effect of brain tumour laterality on patients’ perceived quality of life. J Neurol Neurosurg Psychiatry. 2002;72(3):373–377. Epub 2002/02/28 PubMed PMID: 11861699; PubMed Central PMCID: PMCPMC1737761.
   PubMed Web of Science ®Google Scholar
• Jakola AS, Unsgard G, Solheim O. Quality of life in patients with intracranial gliomas: the impact of modern image-guided surgery. J Neurosurg. 2011;114(6):1622–1630. Epub 2011/ 02/15. PubMed PMID: 21314270.
   PubMed Web of Science ®Google Scholar
• Drewes C, Sagberg LM, Jakola AS, et al. Quality of life in patients with intracranial tumors: does tumor laterality matter? J Neurosurg. 2016:1–8. Epub 2016/ 03/26 PubMed PMID: 27015402. DOI:10.3171/2015.12.jns152252
   Web of Science ®Google Scholar
• Sagberg LM, Iversen DH, Fyllingen EH, et al. Brain atlas for assessing the impact of tumor location on perioperative quality of life in patients with high-grade glioma: a prospective population-based cohort study. Neuroimage Clin. 2019; 21:101658. Epub 2019/ 01/19. PubMed PMID: 30655192.
   PubMed Web of Science ®Google Scholar
• Jakola AS, Solheim O, Gulati S, et al. Is there a response shift in generic health-related quality of life 6 months after glioma surgery? Acta Neurochir (Wien). 2016. Epub 2016/ 12/09. PubMed PMID: 27928631. DOI:10.1007/s00701-016-3040-9
   Web of Science ®Google Scholar
• Bosma I, Reijneveld JC, Douw L, et al. Health-related quality of life of long-term high-grade glioma survivors. Neuro Oncol. 2009;11(1):51–58.
   PubMed Web of Science ®Google Scholar
• Yavas C, Zorlu F, Ozyigit G, et al. Health-related quality of life in high-grade glioma patients: a prospective single-center study. Support Care Cancer. 2012;20(10):2315–2325. Epub 2011/ 12/14. PubMed PMID: 22160582.
   PubMed Web of Science ®Google Scholar
• Brown PD, Maurer MJ, Rummans TA, et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery. 2005;57(3):495–504.
   PubMed Web of Science ®Google Scholar
• Klein M, Engelberts NHJ, van der Ploeg HM, et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol. 2003;54(4):514–520.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Taphoorn MJB, Heimans JJ, et al. Compromised health-related quality of life in patients with low-grade glioma. J clin oncol. 2011;29:4430–4435.
   PubMed Web of Science ®Google Scholar
• Birbeck GL, Hays RD, Cui X, et al. Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia. 2002;43(5):535–538. Epub 2002/05/25. PubMed PMID: 12027916.
   PubMed Web of Science ®Google Scholar
• Chang EF, Potts MB, Keles GE, et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg. 2008;108(2):227–235. PubMed PMID: 18240916.
   PubMed Web of Science ®Google Scholar
• Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J clin oncol. 2002;20(8):2076–2084.
   PubMed Web of Science ®Google Scholar
• Etxaniz O, Carrato C, de Aguirre I, et al. IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas. J Neurooncol. 2017;135(2):273–284. Epub 2017/09/09 PubMed PMID: 28884377.
   PubMed Web of Science ®Google Scholar
• Corell A, Carstam L, Smits A, et al. Age and surgical outcome of low-grade glioma in Sweden. Acta Neurol Scand. 2018. Epub 2018/06/15. PubMed PMID: 29900547. DOI:10.1111/ane.12973
   PubMed Web of Science ®Google Scholar
• Morshed RA, Han SJ, Hervey-Jumper SL, et al. Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60. J Neurooncol. 2019;141(2):383–391. Epub 2018/ 12/01. PubMed PMID: 30498891.
   PubMed Web of Science ®Google Scholar
• Curran WJ Jr., Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993;85(9):704–710. Epub 1993/05/05. PubMed PMID: 8478956.
   PubMed Web of Science ®Google Scholar
• Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol. 2004;6(3):227–235. Epub 2004/ 07/29. PubMed PMID: 15279715; PubMed Central PMCID: PMCPMC1871999.
   PubMed Web of Science ®Google Scholar
• Scott CB, Scarantino C, Urtasun R, et al. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys. 1998;40(1):51–55.
   PubMed Web of Science ®Google Scholar
• Mirimanoff R-O, Gorlia T, Mason W, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J clin oncol. 2006;24(16):2563–2569.
   PubMed Web of Science ®Google Scholar
• Bell EH, Pugh SL, McElroy JP, et al. Molecular-based recursive partitioning analysis model for glioblastoma in the temozolomide era: a correlative analysis based on NRG oncology RTOG 0525. JAMA Oncol. 2017;3(6):784–792. Epub 2017/01/18. PubMed PMID: 28097324; PubMed Central PMCID: PMCPMC5464982.
   PubMed Web of Science ®Google Scholar
• Pallud J, Blonski M, Mandonnet E, et al. Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas. Neuro Oncol. 2013; 15:595–606. Epub 2013/ 02/09. PubMed PMID: 23393207.
   Web of Science ®Google Scholar
• Rees J, Watt H, Jager HR, et al. Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation. Eur J Radiol. 2009;72(1):54–64. Epub 2008/ 07/18. PubMed PMID: 18632238.
   PubMed Web of Science ®Google Scholar
• Stensjoen AL, Berntsen EM, Mikkelsen VE, et al. Does pre-treatment tumor growth hold prognostic information for glioblastoma patients? World Neurosurg. 2017. Epub 2017/ 03/17 PubMed PMID: 28300718. DOI:10.1016/j.wneu.2017.03.012
   Web of Science ®Google Scholar
• Pallud J, Capelle L, Taillandier L, et al. Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro Oncol. 2009;11(2):176–182.
   PubMed Web of Science ®Google Scholar
• Castet F, Alanya E, Vidal N, et al. Contrast-enhancement in supratentorial low-grade gliomas: a classic prognostic factor in the molecular age. J Neurooncol. 2019;143(3):515–523. Epub 2019/05/06. PubMed PMID: 31054099.
   PubMed Web of Science ®Google Scholar
• Jakola AS, Reinertsen I. Radiological evaluation of low-grade glioma: time to embrace quantitative data? Acta Neurochir (Wien). 2019;161(3):577–578. Epub 2019/ 01/30 PubMed PMID: 30693371.
   PubMed Web of Science ®Google Scholar
• Blomstergren A, Rydelius A, Abul-Kasim K, et al. Evaluation of reproducibility in MRI quantitative volumetric assessment and its role in the prediction of overall survival and progression-free survival in glioblastoma. Acta Radiol. 2019;60(4):516–525. Epub 2018/ 07/04 PubMed PMID: 29966430.
   PubMed Web of Science ®Google Scholar
• Gui C, Lau JC, Kosteniuk SE, et al. Radiology reporting of low-grade glioma growth underestimates tumor expansion. Acta Neurochir (Wien). 2019;161(3):569–576. Epub 2019/ 02/14 PubMed PMID: 30756242.
   PubMed Web of Science ®Google Scholar
• Kickingereder P, Isensee F, Tursunova I, et al. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study. Lancet Oncol. 2019;20(5):728–740. Epub 2019/ 04/07. PubMed PMID: 30952559.
   PubMed Web of Science ®Google Scholar
• Jakola AS, Skjulsvik AJ, Myrmel KS, et al. Surgical resection versus watchful waiting in low-grade gliomas. Ann Oncol. 2017;28(8):1942–1948. Epub 2017/05/06. PubMed PMID: 28475680; PubMed Central PMCID: PMCPMC5834105.
   PubMed Web of Science ®Google Scholar
• Delev D, Heiland DH, Franco P, et al. Surgical management of lower-grade glioma in the spotlight of the 2016 WHO classification system. J Neurooncol. 2018. Epub 2018/ 11/24. PubMed PMID: 30467813. DOI:10.1007/s11060-018-03030-w
   Web of Science ®Google Scholar
• Wijnenga MMJ, French PJ, Dubbink HJ, et al. The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis. Neuro Oncol. 2018;20(1):103–112. Epub 2017/10/11. PubMed PMID: 29016833; PubMed Central PMCID: PMCPMC5761503.
   PubMed Web of Science ®Google Scholar
• Obermeyer Z, Emanuel EJ. Predicting the future - big data, machine learning, and clinical medicine. N Engl J Med. 2016;375(13):1216–1219. Epub 2016/09/30. PubMed PMID: 27682033; PubMed Central PMCID: PMCPMC5070532.
   PubMed Web of Science ®Google Scholar
• Mooney SJ, Pejaver V. Big data in public health: terminology, machine learning, and privacy. Annu Rev Public Health. 2018;39:95–112. Epub 2017/ 12/21. PubMed PMID: 29261408; PubMed Central PMCID: PMCPMC6394411.
   PubMed Web of Science ®Google Scholar
• Price WN 2nd, Cohen IG. Privacy in the age of medical big data. Nat Med. 2019;25(1):37–43. Epub 2019/01/09. PubMed PMID: 30617331; PubMed Central PMCID: PMCPMC6376961.
   PubMed Web of Science ®Google Scholar
• He J, Baxter SL, Xu J, et al. The practical implementation of artificial intelligence technologies in medicine. Nat Med. 2019;25(1):30–36. Epub 2019/01/09. PubMed PMID: 30617336.
   PubMed Web of Science ®Google Scholar
• Jakola AS, Moen KG, Solheim O, et al. “No growth” on serial MRI scans of a low grade glioma? Acta Neurochir (Wien). 2013;155(12):2243–2244. Epub 2013/ 10/23. PubMed PMID: 24146183.
   PubMed Web of Science ®Google Scholar
• Berntsen EM, Stensjoen AL, Langlo MS, et al. Volumetric segmentation of glioblastoma progression compared to bidimensional products and clinical radiological reports. Acta Neurochir (Wien). 2019. Epub 2019/ 11/25. PubMed PMID: 31760532. DOI:10.1007/s00701-019-04110-0
   PubMed Web of Science ®Google Scholar
• Obermeyer Z, Lee TH. Lost in thought - the limits of the human mind and the future of medicine. N Engl J Med. 2017;377(13):1209–1211. Epub 2017/09/28. PubMed PMID: 28953443; PubMed Central PMCID: PMCPMC5754014.
   PubMed Web of Science ®Google Scholar